From scientific evidence to HCP education – the evolving role of the medical education specialist

Pharmaceutical Medical Affairs teams are working in an environment where scientific evidence can change rapidly. New biomarkers, treatment sequences, combination regimens, indications and real-world data may alter the questions healthcare professionals need answered before a conventional educational plan has even completed its cycle. The challenge is therefore no longer simply to create more educational content. It is to decide which evidence matters, what healthcare professionals need to understand and how complex information can be translated into education without losing scientific nuance.

That shift is changing the role of the medical education specialist. Increasingly, the specialist is not only a content developer but a bridge between scientific evidence, Medical Affairs strategy and the learning needs of healthcare professionals. This becomes particularly important in complex or fast-moving therapeutic areas, where an educational programme can lose relevance quickly if scientific interpretation and educational design are treated as separate tasks.

Why medical education is becoming more scientifically demanding

The volume of available evidence is only one part of the problem. Medical education must also account for how evidence fits into current practice. A new trial result may be clinically important, but its educational relevance depends on the audience, the treatment setting, existing knowledge gaps and the decisions healthcare professionals are expected to make.

This is especially visible in therapeutic areas where treatment pathways are becoming more individualised. Biomarker-driven decisions, multiple lines of therapy and rapidly evolving standards of care can make it difficult to reduce a topic to a simple scientific message. Educational content has to preserve uncertainty, limitations and clinical context while still giving learners a coherent structure for understanding the evidence.

For Medical Affairs teams, this creates a practical requirement: scientific review and educational planning need to happen together. An accurate summary of the evidence is not automatically effective education. The content must be selected and structured according to a defined educational need rather than according to how much information is available. In this context, Medical education services can support this process when evidence review, educational planning and content development need to remain closely connected.

What does a medical education specialist contribute beyond content development?

A strong medical education specialist contributes scientific judgement before content production begins. This includes reviewing the evidence in context, identifying what is relevant to the intended audience, recognising where understanding may break down and helping define the educational objective that should guide the programme.

The specialist also has to make decisions about emphasis. Clinical evidence often contains more detail than an educational activity can usefully carry. The task is not to simplify by removing scientific complexity indiscriminately, but to distinguish essential evidence from information that adds volume without improving understanding. Important limitations, competing interpretations and areas of evolving evidence should remain visible where they affect the learner’s understanding.

This role becomes particularly valuable when internal Medical Affairs teams already have strategic ownership but need deeper support with evidence interpretation, scientific narrative development or the translation of data into education for a defined HCP audience. In this setting, focused medical education consulting can add scientific and educational depth without transferring strategic ownership of the programme away from the internal team.

Why evidence translation matters as much as evidence generation

Pharmaceutical organisations invest heavily in generating clinical and real-world evidence, but the educational value of that evidence depends on how effectively it is interpreted for the people who need to use it. A publication, congress presentation or clinical study report may establish the scientific basis for education, yet none of these formats is designed around a specific learner need.

Effective medical education therefore requires a second layer of work: translating the evidence into a logical learning journey. That may involve defining the central clinical question, sequencing information so that new concepts build on existing knowledge, explaining why a finding matters in practice and ensuring that the educational message remains balanced and scientifically supportable.

This approach is consistent with established European principles for lifelong learning in healthcare, which emphasize that educational activities should address identified educational needs and provide fair, balanced and objective scientific content. Although the governance and accreditation requirements applicable to medical education depend on the type of activity and jurisdiction, the underlying principle remains the same: education should begin with a genuine learning need and be built around scientifically robust evidence that is relevant to that need.

When should Medical Affairs involve specialist educational expertise?

Specialist input is often most useful before the format and content have been fixed. Early involvement allows the scientific evidence, educational need and intended outcome to shape the programme together rather than forcing an educational objective onto materials that have already been developed.

This can be particularly important when a company is entering a new therapeutic area, preparing for a new indication, responding to rapidly evolving evidence or addressing a clearly identified HCP knowledge gap. It can also help when the internal team has strong strategic expertise but insufficient capacity to perform the detailed evidence review and scientific content development required for a specific initiative.

The objective is not to externalise scientific ownership. Medical Affairs should retain appropriate governance and decision-making. The value of external specialist support lies in strengthening the stages where additional scientific and educational expertise can improve the quality, clarity or speed of programme development.

Why flexible expertise is challenging traditional delivery models

The increasing complexity of medical education is also changing how companies think about external support. Large delivery structures can be appropriate for programmes that require broad operational scale, multiple workstreams or extensive geographic coordination. But they are not the only model.

For some initiatives, the critical requirement is direct access to a small number of people with the right scientific and educational expertise. This is one reason companies may consider alternatives to large CRO-led medical education teams: the size of the external structure does not necessarily determine the quality of scientific interpretation or the relevance of the resulting education.

A more flexible model can allow specialist expertise to be introduced at the stage where it adds the most value – for example, during evidence assessment, educational needs definition or scientific narrative development – while other capabilities are used later for implementation. A focused medical education service can therefore be scaled around a specific stage of the programme rather than requiring every initiative to use the same external structure. The delivery model can follow the work, the scientific need and the level of support required.

How should the impact of medical education be evaluated?

Evaluation should be designed around the educational objective, not added at the end as a reporting exercise. Participation numbers and completion rates can show reach, but they do not by themselves demonstrate that a programme addressed the problem it was designed to solve.

Depending on the purpose of the activity, meaningful evaluation may examine changes in knowledge, confidence, competence or intended practice. The important point is that the measure follows from the identified need. If the programme was developed to clarify a complex treatment concept, for example, success should be assessed in terms of whether learners understood that concept rather than simply whether they attended the activity.

Feedback can then be used to identify remaining knowledge gaps, refine future content and determine whether a different educational approach is required. In this way, evaluation becomes part of an ongoing learning cycle rather than an endpoint.

What will define effective medical education in the future?

As scientific information becomes more specialised and treatment decisions more complex, effective medical education will depend less on the volume of content produced and more on the quality of the connection between evidence, educational need and clinical relevance. The programmes that remain useful are likely to be those that can adapt as evidence changes while retaining a clear scientific purpose.

For the medical education specialist, this places scientific interpretation at the centre of the role. The specialist must be able to move between data and learning design, understand what the intended audience needs from the evidence and preserve the balance and limitations that make the education scientifically credible.

For pharmaceutical Medical Affairs teams, the practical implication is equally clear: the right expertise should be involved at the point where it can shape the programme, not only when content needs to be produced. Whether that expertise sits internally or is accessed through a focused external partner, its value lies in helping turn complex evidence into education that healthcare professionals can understand and use.

Billev Pharma East supports pharmaceutical and biotech Medical Affairs teams with specialist medical education expertise, including evidence interpretation, scientific narrative development and educational content aligned with defined HCP needs.

Sources: 1 – EFPIA – The EFPIA Code, 2 – EACCME – European Accreditation Council for Continuing Medical Education.